North America Biobanks Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America Biobanks Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America Biobanks Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America Biobanks Market Regional Analysis

6.2 North America Biobanks Market Revenue 2019-2028 (US$ Million)

6.3 North America Biobanks Market Forecast Analysis

7. North America Biobanks Market Analysis – by Product and Service

7.1 Equipment

7.1.1 Overview
7.1.2 Equipment: North America Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Consumables

7.2.1 Overview
7.2.2 Consumables: North America Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Service

7.3.1 Overview
7.3.2 Service: North America Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.4 Software

7.4.1 Overview
7.4.2 Software: North America Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America Biobanks Market Analysis – by Sample

8.1 Blood Products

8.1.1 Overview
8.1.2 Blood Products: North America Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Human Tissues

8.2.1 Overview
8.2.2 Human Tissues: North America Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Cell Lines

8.3.1 Overview
8.3.2 Cell Lines: North America Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America Biobanks Market Analysis – by Application

9.1 Regenerative Medicine

9.1.1 Overview
9.1.2 Regenerative Medicine: North America Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Life Science Research

9.2.1 Overview
9.2.2 Life Science Research: North America Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Clinical Research

9.3.1 Overview
9.3.2 Clinical Research : North America Biobanks Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America Biobanks Market – North America Analysis

10.1 Overview

10.2 North America

10.2.1 North America Biobanks Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America Biobanks Market – Revenue and Forecast Analysis – by Country
10.2.1.1 US: North America Biobanks Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 US: North America Biobanks Market Breakdown, by Product and Service
10.2.1.1.2 US: North America Biobanks Market Breakdown, by Sample
10.2.1.1.3 US: North America Biobanks Market Breakdown, by Application

10.2.1.2 Canada: North America Biobanks Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Canada: North America Biobanks Market Breakdown, by Product and Service
10.2.1.2.2 Canada: North America Biobanks Market Breakdown, by Sample
10.2.1.2.3 Canada: North America Biobanks Market Breakdown, by Application

10.2.1.3 Mexico : North America Biobanks Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Mexico : North America Biobanks Market Breakdown, by Product and Service
10.2.1.3.2 Mexico : North America Biobanks Market Breakdown, by Sample
10.2.1.3.3 Mexico : North America Biobanks Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Tecan Trading AG

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 QIAGEN

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Hamilton Company

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Avantor, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 MICRONICS JAPAN CO., LTD.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 BD

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Taylor-Wharton

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Brooks Automation, Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Promega Corporation

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

13.11 SciSafe Inc.

13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

North America Biobanks Market

Analysis By Product and Service (Equipment, Consumables, Service, and Software), Sample (Blood Products, Human Tissues, Cell Lines, and Others), and Application (Regenerative Medicine, Life Science Research, and Clinical Research)